Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 29, Issue 12, Pages 2250-2265
Publisher
American Association for Cancer Research (AACR)
Online
2023-02-08
DOI
10.1158/1078-0432.ccr-22-3298
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous Lymphocytes
- (2022) Nikolaos Zacharakis et al. JOURNAL OF CLINICAL ONCOLOGY
- A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers
- (2022) Ken-ichi Hanada et al. CANCER CELL
- Upstream open reading frames regulate translation of cancer-associated transcripts and encode HLA-presented immunogenic tumor antigens
- (2022) Annika Nelde et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Immunopeptidomic analyses of colorectal cancers with and without microsatellite instability
- (2022) Jenna Cleyle et al. MOLECULAR & CELLULAR PROTEOMICS
- Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer
- (2022) Rom Leidner et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Proteogenomic Integration Strategy Expands the Breadth of Neo-Epitope Sources
- (2022) Haitao Xiang et al. Cancers
- Most non-canonical proteins uniquely populate the proteome or immunopeptidome
- (2021) Maria Virginia Ruiz Cuevas et al. Cell Reports
- A pan-cancer transcriptome analysis of exitron splicing identifies novel cancer driver genes and neoepitopes
- (2021) Ting-You Wang et al. MOLECULAR CELL
- Identification of bacteria-derived HLA-bound peptides in melanoma
- (2021) Shelly Kalaora et al. NATURE
- HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy
- (2021) Ana Marcu et al. Journal for ImmunoTherapy of Cancer
- Immunopeptidogenomics: harnessing RNA-seq to illuminate the dark immunopeptidome
- (2021) K.E. Scull et al. MOLECULAR & CELLULAR PROTEOMICS
- Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer
- (2021) Tamara Ouspenskaia et al. NATURE BIOTECHNOLOGY
- Proteogenomics Uncovers a Vast Repertoire of Shared Tumor-Specific Antigens in Ovarian Cancer
- (2020) Qingchuan Zhao et al. Cancer Immunology Research
- The outcome of ex vivo TIL expansion is highly influenced by spatial heterogeneity of the tumor T-cell repertoire and differences in intrinsic in vitro growth capacity between T-cell clones
- (2020) Isabel C Poschke et al. CLINICAL CANCER RESEARCH
- Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes
- (2020) Chloe Chong et al. Nature Communications
- Identification of the Cryptic HLA-I Immunopeptidome
- (2020) Florian Erhard et al. Cancer Immunology Research
- Anti-tumour immunity induces aberrant peptide presentation in melanoma
- (2020) Osnat Bartok et al. NATURE
- To NMD or Not To NMD: Nonsense-Mediated mRNA Decay in Cancer and Other Genetic Diseases
- (2020) Fran Supek et al. TRENDS IN GENETICS
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
- (2019) Maria R. Parkhurst et al. Cancer Discovery
- Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
- (2019) Alice Newey et al. Journal for ImmunoTherapy of Cancer
- Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
- (2018) Nikolaos Zacharakis et al. NATURE MEDICINE
- Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome
- (2018) Roman Mylonas et al. MOLECULAR & CELLULAR PROTEOMICS
- Noncoding regions are the main source of targetable tumor-specific antigens
- (2018) Céline M. Laumont et al. Science Translational Medicine
- High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome
- (2017) Chloe Chong et al. MOLECULAR & CELLULAR PROTEOMICS
- Translation from unconventional 5′ start sites drives tumour initiation
- (2017) Ataman Sendoel et al. NATURE
- Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
- (2016) Alena Gros et al. NATURE MEDICINE
- T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
- (2016) Eric Tran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames
- (2016) Céline M. Laumont et al. Nature Communications
- Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
- (2016) Michal Bassani-Sternberg et al. Nature Communications
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
- (2013) G. P. Linette et al. BLOOD
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
- (2013) Richard A. Morgan et al. JOURNAL OF IMMUNOTHERAPY
- Incorporation of Transmembrane Hydrophobic Mutations in the TCR Enhance Its Surface Expression and T Cell Functional Avidity
- (2012) A. Haga-Friedman et al. JOURNAL OF IMMUNOLOGY
- Landscape of transcription in human cells
- (2012) Sarah Djebali et al. NATURE
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- DRiPs solidify: progress in understanding endogenous MHC class I antigen processing
- (2011) Jonathan W. Yewdell TRENDS IN IMMUNOLOGY
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started